The HSP90 Inhibitor Onalespib Exerts Synergistic Anti-Cancer Effects When Combined With Radiotherapy: An in Vitro and in Vivo Approach

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-62293-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search